Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-23-032674
Date:2023-05-24
Issuer: QUINCE THERAPEUTICS, INC. (QNCX)
Original Submission Date:

Reporting Person:

LAMOND DAVID
C/O QUINCE THERAPEUTICS, INC.
601 GATEWAY BLVD, STE. SUITE 1250 SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 1.58 2023-05-24 deemed execution date A 27,000 (a) 2033-05-23 common stock 27,000 $1.58 27,000 direct
Footnotes
IDfootnote
f1 the shares subject to the stock option shall vest in equal annual installments over the three-year period following the grant date of may 24, 2023.
WhaleWisdom Logo

Elevate your investments